Correction to Lancet Neurol 2019; 18: 145-54

No authors listed

Published Erratum

No authors listed. Lancet Neurol. 2019 Mar.

. 2019 Mar;18(3):e2.

doi: 10.1016/S1474-4422(19)30014-6. Epub 2019 Jan 18.

No abstract available

Erratum for

Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial.
LeWitt PA, Hauser RA, Pahwa R, Isaacson SH, Fernandez HH, Lew M, Saint-Hilaire M, Pourcher E, Lopez-Manzanares L, Waters C, Rudzínska M, Sedkov A, Batycky R, Oh C; SPAN-PD Study Investigators. LeWitt PA, et al. Lancet Neurol. 2019 Feb;18(2):145-154. doi: 10.1016/S1474-4422(18)30405-8. Lancet Neurol. 2019. PMID: 30663606 Clinical Trial.